1999Anesthesia & AnalgesiaRequires access

Ondansetron Versus Droperidol for Postoperative Nausea and Vomiting

Justin Phillips

Open publisher page 0 citations

Abstract

To the Editor: I read with interest the article comparing the efficacy of ondansetron and droperidol, in which the authors concluded that droperidol compared favorably with ondansetron [1]. They used a dose of 4 mg of ondansetron based on previous studies that concluded that ondansetron 4 mg is the optimal dose to prevent postoperative nausea and vomiting (PONV) [2-4]. However, a more recent quantitative review of 53 randomized, placebo-controlled trials showed that there is a dose-response for oral and IV ondansetron [5]. The most efficacious dose of ondansetron IV to prevent PONV was shown to be 8 mg. Thus, 4 mg does not represent the optimal dose of ondansetron for the prevention of PONV. It would be interesting to repeat the study comparing droperidol 1.25 mg with ondansetron 8 mg. Justin Phillips, FRCA Department of Anaesthesia; Frenchay Hospital; Bristol, BS16 1LE UK

About this research paper

What this paper is about

To the Editor: I read with interest the article comparing the efficacy of ondansetron and droperidol, in which the authors concluded that droperidol compared favorably with ondansetron [1]. They used a dose of 4 mg of ondansetron based on previous studies that concluded that ondansetron 4 mg is the optimal dose to prevent postoperative nausea and vomiting (PONV) [2-4]. However, a more recent quantitative review of 53 randomized, placebo-controlled trials showed that there is a dose-response for oral and IV ondansetron [5]. The most efficacious dose of ondansetron IV to prevent PONV was shown to be 8 mg. Thus, 4 mg does not represent the optimal dose of ondansetron for the prevention of PONV. It would be interesting to repeat the study comparing droperidol 1.25 mg with ondansetron 8 mg. Justin Phillips, FRCA Department of Anaesthesia; Frenchay Hospital; Bristol, BS16 1LE UK

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To the Editor: I read with interest the article comparing the efficacy of ondansetron and droperidol, in which the authors concluded that droperidol compared favorably with ondansetron [1]. They used a dose of 4 mg of ondansetron based on previous studies that concluded that ondansetron 4 mg is the optimal dose to prevent postoperative nausea and vomiting (PONV) [2-4]. However, a more recent quantitative review of 53 randomized, placebo-controlled trials showed that there is a dose-response for oral and IV ondansetron [5]. The most efficacious dose of ondansetron IV to prevent PONV was shown to be 8 mg. Thus, 4 mg does not represent the optimal dose of ondansetron for the prevention of PONV. It would be interesting to repeat the study comparing droperidol 1.25 mg with ondansetron 8 mg. Justin Phillips, FRCA Department of Anaesthesia; Frenchay Hospital; Bristol, BS16 1LE UK

Key concepts: Ondansetron, Droperidol, Medicine, Postoperative nausea and vomiting, Anesthesia, Nausea, Vomiting, Antiemetic

Related papers

Back to paper searchBrowse research topicsOriginal source
Ondansetron Versus Droperidol for Postoperative Nausea and Vomiting — Research Paper | ScholarLens